Kanaly Trust’s Novartis NVS Stock Holding History

Kanaly Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$800K	Buy	12,254 +10,317	+533%	+$669K	0.17%	61
2016 Q3	$137K	Sell	1,937 -1,224	-39%	-$89.2K	0.03%	176
2016 Q2	$234K	Buy	3,161 +585	+23%	+$40.4K	0.05%	139
2016 Q1	$167K	Buy	2,576 +1	+0%	+$68	0.03%	158
2015 Q4	$198K	Sell	2,575 -107	-4%	-$8.5K	0.04%	146
2015 Q3	$221K	Buy	2,682 +20	+0.8%	+$1.78K	0.05%	134
2015 Q2	$235K	Buy	2,662 +1,054	+66%	+$96.7K	0.05%	144
2015 Q1	$142K	Sell	1,608 -51	-3%	-$4.52K	0.03%	180
2014 Q4	$138K	Buy	1,659 +8	+0.5%	+$663	0.03%	200
2014 Q3	$139K	Sell	1,651 -5,779	-78%	-$468K	0.03%	204
2014 Q2	$603K	Sell	7,430 -101	-1%	-$7.94K	0.11%	104
2014 Q1	$574K	Buy	7,531 +307	+4%	+$22.4K	0.11%	102
2013 Q4	$520K	Buy	+7,224	New	+$502K	0.1%	109

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Kanaly Trust's NVS Position: Q4 2016 in Review

Kanaly Trust increased its Novartis (NVS) stake by 533% in Q4 2016, buying an estimated $669K and bringing the position to 12,254 shares worth $800K. The position accounts for 0.17% of the portfolio, ranked #61.

Kanaly Trust first reported a position in NVS in Q4 2013 and has held it in 13 quarters since. 904 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

Kanaly Trust held 12,254 shares of Novartis worth $800K as of Q4 2016.
Kanaly Trust bought 10,317 Novartis shares in Q4 2016, an estimated $669K.
Novartis made up 0.17% of Kanaly Trust's portfolio in Q4 2016, its #61 holding.
Kanaly Trust first reported a position in Novartis in Q4 2013 and has held it in 13 quarters since.
904 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.